- 询价
- Signalway Antibody
- USA
- AP78474
- 2025年07月11日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Store at -20˚C
- 英文名：
Proprotein convertase subtilisin/kexin type 9
- 库存：
详询
- 供应商：
南京莱富赛
- 规格：
详询
host_species:E.coli
purification:>90% by SDS-PAGE
specificity:Human
other_names:PSEC0052,NARC1,Neural apoptosis-regulated convertase 1,Proprotein convertase 9,Subtilisin/kexin-like protease PC9,NARC-1,PC9
accession_no:Q8NBP7
Gene name:PCSK9
calculated_mw:13.42
tag info:His
Immunogen Description:31-152AA
formulation:50mM NaH2PO4, 500mM NaCl Buffer with 500mM Imidazole,10%glycerol(PH8.0)
storage:Store at -20C. (Avoid repeated freezing and thawing.)
Repeated freezing and thawing is not recommended. Store working aliquots at 4℃ for up to one week.
background:Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments (PubMed:18039658). Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation (PubMed:18799458, PubMed:17461796, PubMed:18197702, PubMed:22074827). Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway (PubMed:18660751). Inhibits epithelial Na(+) channel (ENaC)-mediated Na(+) absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验动脉粥样硬化模型小鼠在是实验上存在一定的限制，如没有相关课题时需要一直保种饲养，随后，大量繁殖集齐数量足够年龄相近的小鼠也需要时间，近年来，科学家们建立了一种快速、简便、通用和经济有效的、利用病毒注射野生型小鼠的造模方式：AAV9-Pcsk9D377Y尾静脉注射。 Pcsk9D377Y过表达是近几年新出现的动脉粥样硬化急性模型之一。前蛋白转化酶枯草溶菌素转化酶9 (proprotein convertase subtilisin/kexin type 9, Pcsk9）主要由肝脏表达，介导
Analyses of PCSK9 Post-translational Modifications Using Time-of-Flight Mass Spectrometry
successfully for protein/peptide profiling in disease states and for the detection of protein/peptide biomarkers (1–4). In this chapter, the secreted proprotein convertase subtilisin/kexin 9 (PCSK9), which we study in our lab, is used to demonstrate coupling
技术资料暂无技术资料 索取技术资料
